Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17(6):757–67. https://doi.org/10.1016/S1470-2045(16)00141-8.
Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376(23):2211–2222. https://doi.org/10.1056/NEJMoa1613210.
Sharon C, Straker RI, Li E, Karakousis G, Miura J. National practice patterns in the management of the regional lymph node basin following positive sentinel lymph node biopsy for cutaneous melanoma. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12364-9.
Bredbeck BC, Mubarak E, Zubieta DG, et al. Management of the positive sentinel lymph node in the post-MSLT-II era. J Surg Oncol. 2020;122(8):1778–84. https://doi.org/10.1002/jso.26200.
Article PubMed PubMed Central Google Scholar
Nijhuis AAG, Spillane AJ, Stretch JR, et al. Current management of patients with melanoma who are found to be sentinel node-positive. ANZ J Surg. 2020;90(4):491–6. https://doi.org/10.1111/ans.15491.
留言 (0)